Heart rate variability predicts levels of inflammatory markers: Evidence for the vagal anti-inflammatory pathway

Brain, Behavior, and Immunity

Volumn 49, Issue , 2015, Pages 94-100

  Cooper, Timothy M ^a   McKinley, Paula S ^b,c   Seeman, Teresa E ^d   Choo, Tse Hwei ^c   Lee, Seonjoo ^b,c   Sloan, Richard P ^b,c  

^a Columbia University Medical Center ^*  (United States)

^b Department of Medicine   (United States)

^c NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Heart rate variability; Inflammation; Urinary norepinephrine; Vagal anti inflammatory pathway

Indexed keywords

C REACTIVE PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FIBRINOGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; NORADRENALIN; AUTACOID; BIOLOGICAL MARKER;

ADULT; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; HEART RATE VARIABILITY; HUMAN; INFLAMMATION; MALE; NORADRENALIN URINE LEVEL; PRIORITY JOURNAL; SEX DIFFERENCE; SYMPATHETIC FUNCTION; VAGAL ANTIINFLAMMATORY PATHWAY; VAGUS NERVE; ADRENERGIC SYSTEM; BLOOD; HEART RATE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; URINE;

BIOMARKERS; C-REACTIVE PROTEIN; FEMALE; FIBRINOGEN; HEART RATE; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-6; MALE; MIDDLE AGED; NOREPINEPHRINE; SEX FACTORS; SYMPATHETIC NERVOUS SYSTEM; VAGUS NERVE;

EID: 84940603475     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2014.12.017     Document Type: Article

References (32)

1. Bellinger D.L., Millar B.A., Perez S., Carter J., Wood C., ThyagaRajan S., et al. Sympathetic modulation of immunity: relevance to disease. Cell. Immunol. 2008, 252(1-2):27-56. Epub 2008/03/01; PubMed PMID:18308299; PubMed Central PMCID: PMC3551630. 10.1016/j.cellimm.2007.09.005.
2. Bernik T.R., Friedman S.G., Ochani M., DiRaimo R., Susarla S., Czura C.J., et al. Cholinergic antiinflammatory pathway inhibition of tumor necrosis factor during ischemia reperfusion. J. Vasc. Surg. 2002, 36(6):1231-1236. Epub 2002/12/07. 10.1067/mva.2002.129643.
3. Borovikova L.V., Ivanova S., Zhang M., Yang H., Botchkina G.I., Watkins L.R., et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000, 405(6785):458-462. Epub 2000/06/06. 10.1038/35013070.
4. Brim O.G., Ryff C.D., Kessler R.C. The MIDUS national survey: an overview. How Healthy Are We? A National Study of Well-Being at Midlife 2004, 1-36. University of Chicago Press, Chicago. O.G. Brim, C.D. Ryff, R.C. Kessler (Eds.).
5. DeBoer R.W., Karemaker J.M., Strackee J. Comparing spectra of a series of point events particularly for heart rate variability data. IEEE Trans. Biomed. Eng. 1984, 31(4):384-387. Epub 1984/04/01. 10.1109/tbme.1984.325351.
6. Elenkov I.J., Wilder R.L., Chrousos G.P., Vizi E.S. The sympathetic nerve - an integrative interface between two supersystems: the brain and the immune system. Pharmacol. Rev. 2000, 52(4):595-638. Epub 2000/12/21.
7. Frasure-Smith N., Lesperance F., Irwin M.R., Talajic M., Pollock B.G. The relationships among heart rate variability, inflammatory markers and depression in coronary heart disease patients. Brain Behav. Immun. 2009, 23(8):1140-1147. Epub 2009/07/29. 10.1016/j.bbi.2009.07.005.
8. Gonzalez-Clemente J.M., Vilardell C., Broch M., Megia A., Caixas A., Gimenez-Palop O., et al. Lower heart rate variability is associated with higher plasma concentrations of IL-6 in type 1 diabetes. Eur. J. Endocrinol./Eur. Fed. Endocr. Societies 2007, 157(1):31-38. Epub 2007/07/05. 10.1530/eje-07-0090.
9. Graham J.W., Olchowski A.E., Gilreath T.D. How many imputations are really needed? Some practical clarifications of multiple imputation theory. Prev. Sci. 2007, 8(3):206-213. Epub 2007/06/06. 10.1007/s11121-007-0070-9.
10. Haarala A., Kahonen M., Eklund C., Jylhava J., Koskinen T., Taittonen L., et al. Heart rate variability is independently associated with C-reactive protein but not with Serum amyloid A. The cardiovascular risk in Young Finns study. Eur. J. Clin. Invest. 2011, 41(9):951-957. Epub 2011/02/18. 10.1111/j.1365-2362.2011.02485.x.
11. Huston J.M., Gallowitsch-Puerta M., Ochani M., Ochani K., Yuan R., Rosas-Ballina M., et al. Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis. Crit. Care Med. 2007, 35(12):2762-2768. Epub 2007/09/29. 10.1097/01.ccm.0000288102.15975.ba.
12. Jones J.F., Wang Y., Jordan D. Heart rate responses to selective stimulation of cardiac vagal C fibres in anaesthetized cats, rats and rabbits. J. Physiol. 1995, 489(Pt 1):203-214. Epub 1995/11/15. PubMed PMID: 8583404; PubMed Central PMCID: PMC1156804.
13. Koopman F.A., Stoof S.P., Straub R.H., Van Maanen M.A., Vervoordeldonk M.J., Tak P.P. Restoring the balance of the autonomic nervous system as an innovative approach to the treatment of rheumatoid arthritis. Mol. Med. (Cambridge, Mass) 2011, 17(9-10):937-948. Epub 2011/05/25; PubMed PMID: 21607292; PubMed Central PMCID: PMC3188868. 10.2119/molmed.2011.00065.
14. Lampert R, Bremner JD, Su S, Miller A, Lee F, Cheema F Decreased heart rate variability is associated with higher levels of inflammation in middle-aged men. Am. Heart J. 2008, 156(4):759e1-7. Epub 2008/10/18; PubMed PMID: 18926158; PubMed Central PMCID: PMC2587932. 10.1016/j.ahj.2008.07.009.
15. Little R.J.A., Rubin D.B. Statistical Analysis with Missing Data 2002, xv. Wiley, Hoboken, N.J., 381 pp. 2nd ed.
16. Peterson C.Y., Krzyzaniak M., Coimbra R., Chang D.C. Vagus nerve and postinjury inflammatory response. Arch. Surg. (Chicago, Ill: 1960) 2012, 147(1):76-80. Epub 2012/02/23.
17. Redwine L., Snow S., Mills P., Irwin M. Acute psychological stress: effects on chemotaxis and cellular adhesion molecule expression. Psychosom. Med. 2003, 65(4):598-603. Epub 2003/07/29.
18. Rosas-Ballina M., Olofsson P.S., Ochani M., Valdes-Ferrer S.I., Levine Y.A., Reardon C., et al. Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit. Science (New York, NY) 2011, 334(6052):98-101. Epub 2011/09/17. 10.1126/science.1209985.
19. Rubin D.B. Inference and missing data. Biometrika 1976, 63(3):581-590. PubMed PMID: ISI:A1976CP66700021. 10.1093/Biomet/63.3.581.
20. Ryff, C., Almeida, D.M., Ayanian, J.S., Carr, D.S., Cleary, P.D., Coe, C., et al., 2012. National Survey of Midlife Development in the United States (MIDUS II), 2004-2006. ICPSR04652-v6 ed: Inter-university Consortium for Political and Social Research (ICPSR).
21. Saeed R.W., Varma S., Peng-Nemeroff T., Sherry B., Balakhaneh D., Huston J., et al. Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation. J. Exp. Med. 2005, 201(7):1113-1123. Epub 2005/04/06; PubMed PMID: 15809354; PubMed Central PMCID: PMC2213139. 10.1084/jem.20040463.
22. Schafer J.L. Analysis of Incomplete Multivariate Data 1997, Chapman & Hall, New York.
23. Singh P., Hawkley L.C., McDade T.W., Cacioppo J.T., Masi C.M. Autonomic tone and C-reactive protein: a prospective population-based study. Clin. Auton. Res. 2009, 19(6):367-741950. Epub 2009/06/09; PubMed PMID:4232; PubMed Central PMCID: PMC2783459. 10.1007/s10286-009-0019-0.
24. Sloan R.P., McCreath H., Tracey K.J., Sidney S., Liu K., Seeman T. RR interval variability is inversely related to inflammatory markers: the CARDIA study. Mol. Med. (Cambridge, Mass) 2007, 13(3-4):178-184. Epub 2007/06/27.PubMed PMID: 17592552; PubMed Central PMCID: PMC1892756. 10.2119/2006-00112.Sloan.
25. Stuckey M.I., Petrella R.J. Heart rate variability in type 2 diabetes mellitus. Crit. Rev. Biomed. Eng. 2013, 41(2):137-147. Epub 2013/01/01.
26. Tateishi Y., Oda S., Nakamura M., Watanabe K., Kuwaki T., Moriguchi T., et al. Depressed heart rate variability is associated with high IL-6 blood level and decline in the blood pressure in septic patients. Shock (Augusta, Ga) 2007, 28(5):549-553. Epub 2007/12/14. 10.1097/shk.0b013e3180638d1.
27. Thayer J.F., Fischer J.E. Heart rate variability, overnight urinary norepinephrine and C-reactive protein: evidence for the cholinergic anti-inflammatory pathway in healthy human adults. J. Intern. Med. 2009, 265(4):439-447. Epub 2008/11/21. 10.1111/j.1365-2796.2008.02023.x.
28. Tracey K.J. Physiology and immunology of the cholinergic antiinflammatory pathway. J. Clin. Investig. 2007, 117(2):289-296. Epub 2007/02/03; PubMed PMID: 17273548; PubMed Central PMCID: PMC1783813. 10.1172/jci30555.
29. Viswanathan K., Dhabhar F.S. Stress-induced enhancement of leukocyte trafficking into sites of surgery or immune activation. Proc. Natl. Acad. Sci. U.S.A. 2005, 102(16):5808-5813. Epub 2005/04/09; PubMed PMID: 15817686; PubMed Central PMCID: PMC556309. 10.1073/pnas.0501650102.
30. von Känel R., Nelesen R.A., Mills P.J., Ziegler M.G., Dimsdale J.E. Relationship between heart rate variability, interleukin-6, and soluble tissue factor in healthy subjects. Brain Behav. Immun. 2008, 22(4):461-468. Epub 2007/11/06; PubMed PMID: 17977694; PubMed Central PMCID: PMC2373608. 10.1016/j.bbi.2007.09.009.
31. Wang H., Liao H., Ochani M., Justiniani M., Lin X., Yang L., et al. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat. Med. 2004, 10(11):1216-1221. Epub 2004/10/27. 10.1038/nm1124.
32. Wang H., Yu M., Ochani M., Amella C.A., Tanovic M., Susarla S., et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 2003, 421(6921):384-388. Epub 2003/01/01. 10.1038/nature01339.